Dr. Karthikkumar Venkatachalam
Dr. Richard Jayaraj
Neuroscientist with over 15 years of international research experience across four countries, specializing in multi-disciplinary pre-clinical and clinical projects spanning in silico, in vitro, and in vivo disease models and human biomarkers. I started my research journey from a humble background, without access to sophisticated labs or resources, yet went on to complete my PhD […]
Catalina Vasilescu, PhD
Translational scientist, 20 years in mitochondrial biology, rare genetic disease, genomic medicine, and oligonucleotide therapeutics. Co-author on 15 peer-reviewed publications including JACC, Nature, Nature Genetics, and Cell Reports Medicine. Medix Prize for Clinical Research. Consulting services: Antisense oligonucleotide and splice-correction programs: ASO design and tiling, cell-based screening cascades, quantitative rescue assays, efficacy readouts. Rare disease […]
Sudipta Dutta
A growth-oriented researcher with over 10 years of experience in endocrinology, cell and molecular biology, in vivo studies. Ability to learn new techniques; experienced in data analysis, data interpretation, data management, and solving complex problems. Strong oral and written communication skills, cross-functional team collaboration and ability to present scientific data and concepts as evidenced by […]
Gwang Jin (Josephus) Kim
Senior Data Scientist computational biologist PhD Molecular Medicine with long-term experience delivering end-to-end analytics across disease research and Pharma Biotech environments from multi-omics single-cell bulk RNA-seq ChIP/ATAC to applied ML CNNs sequence models and robust reproducible pipelines. Clinical-facing background from a university hospital setting Freiburg Germany worked with patient-derived cohort data under ethics approval informed […]
MEHDI SOLEYMANI-GOLOUJEH, Ph.D.
Postdoctoral scientist with 2+ years of post-PhD experience designing and characterizing engineered human pluripotent stem cell lines at the UCSF Diabetes Center. Applies CRISPR/Cas9-based genome engineering, HDR-oriented knock-in/knockout strategies, TALEN-related workflows, and lentiviral effector systems to build hPSC-derived models of inflammation-driven cell death, with multi-lineage differentiation experience relevant to neural and microglial lineage workflows used […]
Jeffrey M. Skredenske
Accomplished expert in biologics (upstream and downstream) and bioconjugation with deep experience in process development, manufacturing, and process validation. Demonstrated success leading cross-functional teams and managing strategic CDMO partnerships to advance monoclonal antibody and antibody-drug conjugate programs through early- and late-phase clinical trials and IND and BLA preparation and submission. Strong background in high-impact project […]
Yasmeen Mohamed Attia, PhD
I am a Professor of Pharmacology and Toxicology at the Faculty of Pharmacy, The British University in Egypt, a Fulbright Visiting Scholar, Postgraduate Programme Director and Leader of the Drug Research and Development Group (DRD-G) at the Health Research Center of Excellence. My expertise spans translational experimental research, cancer pharmacology, immune-metabolic regulation, drug response modelling […]